Skip to content

Five Point Holdings, Inc. FPH Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Land sales39%+21.9%

Other financials

Income statement

See full
Revenue$13.6M+3.2%
Net income-$2.2M-110%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$333.6M-37.0%
Total debt$453.0M-15.6%
Total equity$2.3B+4.2%
Total assets$3.2B+0.9%

Cash flow

See full
Operating cash flow-$44.5M-178%
CapEx--100%
Free cash flow-$44.5M-179%

Valuation

See full
Market cap$371.56M-3.3%
Enterprise value$491.02M+25.2%
P/E8.2×+3.9×
P/S3.4×+1.8×

Profitability

See full
Net margin41.2%+4.1pp
FCF margin3.5%-78.8pp

Returns & leverage

See full
Return on equity2%-2.2pp
Debt / equity0.2×0.0×